These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 35254622)

  • 21. Does nailfold capillaroscopy help predict future outcomes in systemic sclerosis? A systematic literature review.
    Paxton D; Pauling JD
    Semin Arthritis Rheum; 2018 Dec; 48(3):482-494. PubMed ID: 29602558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
    Khanna D; Distler O; Avouac J; Behrens F; Clements PJ; Denton C; Foeldvari I; Giannini E; Huscher D; Kowal-Bielecka O; Lovell D; Matucci-Cerinic M; Mayes M; Merkel PA; Nash P; Opitz CF; Pittrow D; Rubin L; Seibold JR; Steen V; Strand CV; Tugwell PS; Varga J; Zink A; Furst DE; ;
    J Rheumatol; 2009 Oct; 36(10):2356-61. PubMed ID: 19820225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: A systematic literature review.
    Pauling JD; Hackett N; Guida A; Merkel PA
    Semin Arthritis Rheum; 2020 Oct; 50(5):1114-1130. PubMed ID: 32920325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on systemic sclerosis.
    McCray CJ; Mayes MD
    Curr Allergy Asthma Rep; 2015 May; 15(5):25. PubMed ID: 26139334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy.
    Henry TW; Mendoza FA; Jimenez SA
    Autoimmun Rev; 2019 Nov; 18(11):102396. PubMed ID: 31520794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on biomarker discovery and use in systemic sclerosis.
    Matsushita T; Takehara K
    Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comorbidity burden in systemic sclerosis: beyond disease-specific complications.
    Pagkopoulou E; Arvanitaki A; Daoussis D; Garyfallos A; Kitas G; Dimitroulas T
    Rheumatol Int; 2019 Sep; 39(9):1507-1517. PubMed ID: 31300848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adults.
    Morrisroe K; Stevens W; Proudman S; Nikpour M
    Int J Rheum Dis; 2017 Nov; 20(11):1728-1750. PubMed ID: 29076640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.
    Castelino FV; Varga J
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1077-90. PubMed ID: 24168414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions.
    Bellando-Randone S; Matucci-Cerinic M
    Curr Rheumatol Rep; 2017 Sep; 19(10):65. PubMed ID: 28921059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modern perspective on the development conditions and diagnosis of systemic sclerosis].
    Wielosz E
    Wiad Lek; 2017; 70(4):855-859. PubMed ID: 29064817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial.
    van den Hombergh WMT; Kersten BE; Knaapen-Hans HKA; Thurlings RM; van der Kraan PM; van den Hoogen FHJ; Fransen J; Vonk MC
    Trials; 2018 Aug; 19(1):449. PubMed ID: 30134971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
    Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes.
    Ingegnoli F; Carmona L; Castrejon I
    Semin Arthritis Rheum; 2017 Apr; 46(5):609-614. PubMed ID: 27839740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
    Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic sclerosis: An update in 2016.
    Desbois AC; Cacoub P
    Autoimmun Rev; 2016 May; 15(5):417-26. PubMed ID: 26802722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting very early systemic sclerosis: a case-based review.
    Melissaropoulos K; Kraniotis P; Bogdanos D; Dimitroulas T; Sakkas L; Daoussis D
    Rheumatol Int; 2019 Nov; 39(11):1961-1970. PubMed ID: 31254002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B Cells.
    Melissaropoulos K; Iliopoulos G; Sakkas LI; Daoussis D
    Front Immunol; 2022; 13():925741. PubMed ID: 35812378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic sclerosis. A clinical overview.
    Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
    Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical approach to the therapy of systemic sclerosis.
    Czirják L
    Z Rheumatol; 2004 Dec; 63(6):451-6. PubMed ID: 15605208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.